Studies on Hospital Pharmaceutical Manufacturing (VI) Cost Comparison of Six Times versus Twice Per Year Preparations of 1% Methylene Blue Injection by a Cost Saving Analysis

Moemi Saito, Machiko Watanabe, M. Hoshi, T. Mikawa, H. Yoshida, K. Edo
{"title":"Studies on Hospital Pharmaceutical Manufacturing (VI) Cost Comparison of Six Times versus Twice Per Year Preparations of 1% Methylene Blue Injection by a Cost Saving Analysis","authors":"Moemi Saito, Machiko Watanabe, M. Hoshi, T. Mikawa, H. Yoshida, K. Edo","doi":"10.5649/JJPHCS1975.26.164","DOIUrl":null,"url":null,"abstract":"For the purpose of determining the shelf life of 1% Methylene Blue (MB) injection, its stability was investigated under 4 storage conditions for 30 weeks. The content of MB in 1% MB injection started to decrease at 5°C in the dark 4 weeks after preparation, but no significant differences were observed under three other storage conditions (at room temperature (22.0±0.5°C) and at 40°C in the dark and at room temperature (22.0±0.5°C) in 1000 Lux fluorescent light) for 30 weeks. According to these results, we changed the shelf life of 1% MB injection from 2 to 6 months and the frequency of preparation from six times to twice/year. The unit cost before and after the change of shelf life was compared. One unit cost calculated according to materials costs and labor costs was ¥2, 738.6 during the 1993-1995 period (six times preparations/year), while it was ¥1, 545.9 during the 1996-1998 period (twice preparations/year). A cost savings of ¥1, 192.7/ampule (43.6%) was produced by changing the frequency of preparation from six times to twice/year. In addition, the discard cost for 1% MB injection past its shelf life was estimated. A discard cost saving of ¥85, 766.8/year (75.2%) was achieved by changing the frequency of preparation from six times to twice/year. Furthermore, the working hours were reduced by 9.58 hours/man/year and it allowed pharmacists to utilize the extra time gained by changing the frequency to other work.","PeriodicalId":14621,"journal":{"name":"Japanese Journal of Hospital Pharmacy","volume":"8 1","pages":"164-170"},"PeriodicalIF":0.0000,"publicationDate":"2000-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/JJPHCS1975.26.164","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

For the purpose of determining the shelf life of 1% Methylene Blue (MB) injection, its stability was investigated under 4 storage conditions for 30 weeks. The content of MB in 1% MB injection started to decrease at 5°C in the dark 4 weeks after preparation, but no significant differences were observed under three other storage conditions (at room temperature (22.0±0.5°C) and at 40°C in the dark and at room temperature (22.0±0.5°C) in 1000 Lux fluorescent light) for 30 weeks. According to these results, we changed the shelf life of 1% MB injection from 2 to 6 months and the frequency of preparation from six times to twice/year. The unit cost before and after the change of shelf life was compared. One unit cost calculated according to materials costs and labor costs was ¥2, 738.6 during the 1993-1995 period (six times preparations/year), while it was ¥1, 545.9 during the 1996-1998 period (twice preparations/year). A cost savings of ¥1, 192.7/ampule (43.6%) was produced by changing the frequency of preparation from six times to twice/year. In addition, the discard cost for 1% MB injection past its shelf life was estimated. A discard cost saving of ¥85, 766.8/year (75.2%) was achieved by changing the frequency of preparation from six times to twice/year. Furthermore, the working hours were reduced by 9.58 hours/man/year and it allowed pharmacists to utilize the extra time gained by changing the frequency to other work.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
1%亚甲蓝注射液6次/年配制与2次/年配制的医院制药厂成本比较及成本节约分析
为确定1%亚甲基蓝注射液的保质期,研究了其在4种贮存条件下30周的稳定性。1% MB注射液中MB的含量在制备4周后5℃暗置条件下开始下降,但在室温(22.0±0.5℃)、40℃暗置条件和室温(22.0±0.5℃,1000 Lux荧光灯下)保存30周后未见显著差异。根据这些结果,我们将1% MB注射液的保质期从2个月改为6个月,制备频率从6次/年改为2次/年。比较了改变保质期前后的单位成本。按材料成本和人工成本计算,1993-1995年期间单位成本为2738.6元(6次准备/年),1996-1998年期间单位成本为1545.9元(2次准备/年)。通过将配制频率从每年6次改为每年2次,每安瓿可节省费用1192.7元(43.6%)。此外,估计了超过保质期的1% MB注射剂的废弃成本。通过将准备频率从每年6次改为每年2次,可节省85,766.8元/年(75.2%)的废弃成本。此外,工作时数亦减少9.58小时/人/年,药剂师可透过改变工作频率,利用额外的时间从事其他工作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Assessment and Analysis of the Assessment Criteria for Meta-Analysis Articles:─ Management of Diabetes Pharmacotherapy Based on Meta-Analysis Articles ─ ベネコートBMI-40とBMI-60との苦味マスキング効果の比較 「創薬ボランティアのしおり」,「被験者管理票」の利用と治験コーディネーター業務 Hemodializability of Pimobendan and Its Active Metabolite, UD-CG 212, in Patients with Congestive Heart Failure Undergoing Hemodialysis An Investigation into the Current Management for Patients with Long-Term Withdrawal Periods from Drugs
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1